Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
12.55 USD | -1.72% | -4.40% | -13.70% |
Kurzporträt
Mitarbeiterzahl: 174
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Samuel Blackman
FOU | Founder | 55 | 01.11.18 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 01.09.20 |
Charles York
DFI | Director of Finance/CFO | 47 | 01.02.21 |
Mike Pregih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Adam Dubow
CMP | Compliance Officer | 57 | 01.10.22 |
Davy Chiodin
PRN | Corporate Officer/Principal | - | - |
Lauren Merendino
PRN | Corporate Officer/Principal | 49 | 01.05.23 |
Jaa Roberson
HRO | Human Resources Officer | - | 13.09.21 |
Raphaël Rousseau
PRN | Corporate Officer/Principal | 55 | 01.05.23 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 17.08.21 |
Natalie Holles
BRD | Director/Board Member | 51 | 01.02.21 |
John Josey
BRD | Director/Board Member | 63 | 01.09.20 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 01.09.20 |
Director/Board Member | 37 | 01.12.19 | |
Director/Board Member | 48 | 01.03.21 | |
William Grossman
BRD | Director/Board Member | 54 | 17.01. |
Garry Nicholson
CHM | Chairman | 69 | 12.09.22 |
Habib Dable
BRD | Director/Board Member | 54 | 17.01. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 87 389 859 | 70 160 882 ( 80,28 %) | 0 | 80,28 % |
Unternehmenskontakt
Day One Biopharmaceuticals, Inc.
2000 Sierra Point Parkway Suite 501
94005, Brisbane
+
http://www.dayonebio.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-13.70% | 1.12 Mrd. | |
+48.50% | 57.87 Mrd. | |
+41.65% | 40.25 Mrd. | |
-6.63% | 39.94 Mrd. | |
-5.96% | 28.54 Mrd. | |
+13.06% | 26.4 Mrd. | |
-19.88% | 19.33 Mrd. | |
+31.65% | 12.4 Mrd. | |
+0.48% | 12.23 Mrd. | |
+25.05% | 12.2 Mrd. |
- Börse
- Aktien
- A3CQ56 Aktie
- Unternehmen Day One Biopharmaceuticals, Inc.